Compare Vanguard Total Bond Market Index Fund ETF (BND) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Total Bond Market Index Fund ETF vs IDEXX Laboratories, Inc. — how do they compare? Vanguard Total Bond Market Index Fund ETF trades at $72.63, while IDEXX Laboratories, Inc. trades at $534.38 (market cap $42.65B). Which is the better fit depends on your goals.
| BND | IDXX | |
|---|---|---|
52-Week High | $75.17 | $766.68 |
52-Week Low | $72.45 | $514.61 |
Market Cap | — | $42.65B |
Sector | — | Health |
Enterprise Value | — | $43.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BND trades at $72.50, down 0.37% with a bearish technical outlook showing 19 sell signals versus 4 buy signals. The ETF faces pressure from rising interest rate expectations, though recent dividend payments of $0.24-$0.25 provide income stability. Fixed income ETFs have seen renewed investor interest with $100 billion flowing into cash ETFs recently, indicating defensive positioning.
The bond ETF faces headwinds from potential Fed rate hikes but offers diversification benefits. Key risks include interest rate sensitivity and competition from higher-yielding alternatives. Long-term investors may find value in BND's broad market exposure and low costs despite near-term technical weakness.
IDXX trades at $564.09, up 0.09% with neutral technical signals. The stock shows strong fundamentals with revenue growth to $4.3B in 2025 and consistent earnings beats. Analyst consensus is bullish (59% Buy) with improving cash flow trends. Recent news highlights AI integration in medical devices and upcoming Q2 2026 earnings.
Outlook remains positive driven by innovation and market leadership in pet healthcare. Risks include high valuation multiples and competitive pressures. Institutional sentiment supports growth, but investors should monitor execution against elevated expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vanguard Total Bond Market Index Fund ETF
This index measures the performance of a wide spectrum of public, investment-grade, taxable, fixed income securities in the US, including government, corporate, and international dollar-denominated bonds, as well as mortgage-backed and asset-backed securities-all with maturities of more than 1 year. All of the fund's investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the index.
Read more on BND →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
